We are live on
!
Find out more
SA
Sicart Associates Portfolio holdings
AUM
$389M
1-Year Est. Return
42.46%
This Fund
S&P 500
This Quarter
Est. Return
+1.92%
1 Year Est. Return
+42.46%
3 Year Est. Return
+89.06%
5 Year Est. Return
+118.65%
10 Year Est. Return
–
AUM
$191M
AUM Growth
+$23.3M
(+14%)
Cap. Flow
+$20.6M
Cap. Flow
% of AUM
10.81%
Top 10 Holdings %
Top 10 Hldgs %
51.45%
Holding
95
New
5
Increased
13
Reduced
26
Closed
7
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Ionis Pharmaceuticals
IONS
|
+$7.85M |
| 2 |
Merck
MRK
|
+$4.29M |
| 3 |
Intel
INTC
|
+$4.18M |
| 4 |
Campbell Soup
CPB
|
+$4.18M |
| 5 |
Procter & Gamble
PG
|
+$3.88M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$727K |
| 2 |
Capital One
COF
|
+$575K |
| 3 |
Boeing
BA
|
+$516K |
| 4 |
Ford
F
|
+$443K |
| 5 |
Nektar Therapeutics
NKTR
|
+$436K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 19.73% |
| 2 | Energy | 15.98% |
| 3 | Technology | 13.78% |
| 4 | Materials | 8.52% |
| 5 | Consumer Staples | 7.29% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
1
Ionis Pharmaceuticals
IONS
$8.6B
| $21.8M | 11.45% |
523,894
+177,082
| +51% | +$7.85M |
|
2
SPDR Gold Trust
GLD
$131B
| $16M | 8.37% |
134,584
-360
| -0.3% | -$44.6K |
|
3
Patterson-UTI
PTEN
$3.98B
| $11.9M | 6.23% |
659,595
-545
| -0.1% | -$10.9K |
|
|
4
Intel
INTC
$455B
| $10.2M | 5.33% |
204,538
+78,785
| +63% | +$4.18M |
|
5
ProShares Short High Yield
SJB
$51.8M
| $7.9M | 4.14% |
340,505
+5,125
| +2% | +$119K |
|
|
PXD
6
DELISTED
Pioneer Natural Resource Co.
PXD
| $7.17M | 3.76% |
37,875
+50
| +0.1% | +$9.58K |
|
7
Nutrien
NTR
$33.2B
| $6.68M | 3.5% |
122,148
-1,810
| -1% | -$89.8K |
|
8
APA Corp
APA
$13.2B
| $5.94M | 3.12% |
127,095
+1,330
| +1% | +$55.2K |
|
|
9
Merck
MRK
$322B
| $5.45M | 2.86% |
93,437
+76,117
| +439% | +$4.29M |
|
10
Fortuna Silver Mines
FSM
$2.55B
| $5.14M | 2.7% |
905,490
+13,000
| +1% | +$72.7K |
|
|
11
Campbell Soup
CPB
$6.55B
| $5.02M | 2.63% |
123,770
+107,270
| +650% | +$4.18M |
|
|
12
Procter & Gamble
PG
$336B
| $4.65M | 2.44% |
59,579
+51,560
| +643% | +$3.88M |
|
13
OraSure Technologies
OSUR
$279M
| $3.93M | 2.06% |
238,524
-3,425
| -1% | -$57.8K |
|
14
SLB Ltd
SLB
$73.6B
| $3.65M | 1.91% |
54,066
| – | – |
|
15
Corning
GLW
$119B
| $3.46M | 1.81% |
125,825
+3,200
| +3% | +$88.4K |
|
|
CVSA
16
Covista Inc
CVSA
$4.25B
| $3.22M | 1.69% |
66,985
-400
| -0.6% | -$19.1K |
|
17
Clean Harbors
CLH
$16.5B
| $2.91M | 1.53% |
52,440
-200
| -0.4% | -$10.3K |
|
18
ProShares Short S&P500
SH
$907M
| $2.9M | 1.52% |
24,750
-188
| -0.8% | -$22.2K |
|
19
Alphabet (Google) Class A
GOOGL
$4.36T
| $2.87M | 1.5% |
50,800
| – | – |
|
20
Vanguard Total International Stock ETF
VXUS
$155B
| $2.81M | 1.47% |
51,957
| – | – |
|
|
CTXS
21
DELISTED
Citrix Systems Inc
CTXS
| $2.74M | 1.44% |
26,170
-450
| -2% | -$46.3K |
|
|
22
Microsoft
MSFT
$3.45T
| $2.2M | 1.15% |
22,296
-7,500
| -25% | -$727K |
|
23
Apple
AAPL
$4.54T
| $1.94M | 1.02% |
41,960
-1,200
| -3% | -$54.4K |
|
24
DuPont de Nemours
DD
$18.5B
| $1.89M | 0.99% |
11,340
| – | – |
|
25
McDonald's
MCD
$192B
| $1.84M | 0.96% |
11,727
-100
| -0.8% | -$16.2K |
|
Similar funds
AIM
WCM
HP
P8IP
PFPGI
PG
S
LHC
Sicart Associates's Q2 2018 Portfolio in Review
As of Q2 2018, Sicart Associates held 95 positions worth $191M, up 14% from $167M the previous quarter. Its ten largest holdings account for 51% of the portfolio.
Sicart Associates deployed $20.6M of net new capital in Q2 2018, opening 5 new positions and adding to 13 existing holdings. Its largest new stake was Invesco China Small Cap ETF: 36,660 shares worth $1.08M.
By sector, the portfolio is most concentrated in Healthcare at 20% of assets, up from 16% a quarter earlier, followed by Energy and Technology.
On the sell side, the largest reduction was Microsoft, an estimated $727K trimmed.
- Sicart Associates's largest Q2 2018 buy was Invesco China Small Cap ETF: 36,660 shares worth $1.08M.
- Sicart Associates added most to Ionis Pharmaceuticals in Q2 2018, an estimated $7.85M increase.
- Sicart Associates's biggest Q2 2018 reduction was Microsoft, cutting an estimated $727K.
- Sicart Associates fully exited Capital One in Q2 2018, selling an estimated $575K.
- Sicart Associates's ten largest holdings make up 51% of its $191M portfolio in Q2 2018.
- Sicart Associates opened 5 new positions and closed 7 in Q2 2018.
- Sicart Associates's portfolio value rose 14% quarter-over-quarter to $191M.
Based on Sicart Associates's 13F filing for Q2 2018, filed 19 Jul 2018.